Navigation Links
Great Lakes NeuroTechnologies Awarded Patent For Technology To Treat Parkinson's Disease With Brain Stimulation During Sleep
Date:7/22/2013

VALLEY VIEW, Ohio, July 22, 2013 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms. The claims cover a system and method including a wearable apparatus to position an array of electrodes on the surface of the scalp, provide low dose stimulation to the brain using transcranial direct current stimulation (tDCS), and delivering this stimulation during different stages of sleep. While deep brain stimulation has shown efficacy for treating movement disorders such as Parkinson's disease, non-invasive technologies such as tDCS may provide additional options for patients. Delivering stimulation therapy during sleep may target brain states likely to improve motor symptoms, as well as minimize patient burden since the therapy would occur while they are sleeping.

"While most of our previous work has focused on diagnostics for Parkinson's disease, we also recognize new opportunities for therapy could have a significant impact on patient quality of life." says Dustin Heldman, PhD, Principal Investigator and Biomedical Research Manager. To address the growing movement disorders market, Great Lakes NeuroTechnologies has been committed to the commercialization of its Kinesia [ http://glneurotech.com/kinesia/proview/ ] medical technology platforms. "There is evidence that treating the brain with transcranial direct current stimulation using a non-invasive system can improve Parkinson's symptoms. While current approaches aim to target the location of stimulation to the brain, this approach is targeting the timing of stimulation, by delivering it during sleep." Dr. Heldman also thanked the National Institute of Neurological Disorders and Stroke and the National Institute on Aging for their continued support of these technologies. An ongoing Phase I clinical study (1R43NS077652-01) is evaluating efficacy of the technology in patients.

Great Lakes NeuroTechnologies is committed to building its intellectual property portfolio with new applications stemming from many on-going clinical studies. "These allowed patent claims continue to build on our success in applying for and securing intellectual property for our innovative product and services pipeline targeted toward movement disorders. Strategically, it also represents a bifurcated shift in our portfolio to cover not only diagnostics but certain therapies that leverage key components of our diagnostic technology", says Brian Kolkowski, PhD, Executive Vice-President and General Counsel. "As our technology continues to grow commercially in both domestic and international markets, our growing patent portfolio will help to provide strategic advantage for our company by protecting technology in our targeted markets."

About Great Lakes NeuroTechnologies
Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.

Media Contact
Amelia Earhart, 216-361-5410 - aaearhart@GLNeuroTech.com

 



 

 


'/>"/>
SOURCE Great Lakes NeuroTechnologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mitsubishi Chemical Medience and LabCorp Clinical Trials Announce Master Service Agreement to Offer Clients Greater Access to Global Central Lab Services
2. Surveyed U.S. and European Neurologists Identify Better Seizure-Free Efficacy as One of the Greatest Unmet Needs in Treating Partial-Onset Seizures in Refractory Epilepsy Patients
3. For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate Cancer, Surveyed Oncologists Indicate that Improved Symptom Control and Quality of Life is one of the Greatest Unmet Needs
4. For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
5. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
6. Breakthrough "AffloVest" Greatly Advances Respiratory Care
7. A Greater Effect on Depressive Symptoms than Current Treatments is One of the Greatest Unmet Needs in Treatment-Resistant Depression
8. Smart911 and In Case of Emergency Standard Partner to Enhance Availability of Life Saving Data for Greater Emergency Response
9. Cancer drug shortages mean higher costs and greater risk for patients
10. The 113th Canton Fair: "Great Opportunities for Emerging Markets"
11. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... professionals, announced today its affiliation with Tennessee Counseling Association. This new ... network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
Breaking Medicine News(10 mins):